WO2002058725A3 - Peptides non glycosyles derives de la proteine g du vrs et leur utilisation dans un vaccin - Google Patents
Peptides non glycosyles derives de la proteine g du vrs et leur utilisation dans un vaccin Download PDFInfo
- Publication number
- WO2002058725A3 WO2002058725A3 PCT/FR2002/000270 FR0200270W WO02058725A3 WO 2002058725 A3 WO2002058725 A3 WO 2002058725A3 FR 0200270 W FR0200270 W FR 0200270W WO 02058725 A3 WO02058725 A3 WO 02058725A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- rsv
- vaccine
- protein
- peptides derived
- glycosylated peptides
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02700379A EP1353690A2 (fr) | 2001-01-23 | 2002-01-23 | Peptides non glycosyles derives de la proteine g du vrs et leur utilisation dans un vaccin |
AU2002233457A AU2002233457A1 (en) | 2001-01-23 | 2002-01-23 | Non-glycosylated peptides derived from the rsv g protein and use thereof in a vaccine |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR01/00875 | 2001-01-23 | ||
FR0100875A FR2819810B1 (fr) | 2001-01-23 | 2001-01-23 | Peptides non glycosyles derives de la proteine g du vrs et leur utilisation dans un vaccin |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002058725A2 WO2002058725A2 (fr) | 2002-08-01 |
WO2002058725A3 true WO2002058725A3 (fr) | 2003-01-09 |
Family
ID=8859130
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR2002/000270 WO2002058725A2 (fr) | 2001-01-23 | 2002-01-23 | Peptides non glycosyles derives de la proteine g du vrs et leur utilisation dans un vaccin |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1353690A2 (fr) |
AU (1) | AU2002233457A1 (fr) |
FR (1) | FR2819810B1 (fr) |
WO (1) | WO2002058725A2 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9211342B2 (en) | 2010-01-22 | 2015-12-15 | Novo Nordisk Healthcare Ag | Stable growth hormone compounds resistant to proteolytic degradation |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7368537B2 (en) * | 2003-07-15 | 2008-05-06 | Id Biomedical Corporation Of Quebec | Subunit vaccine against respiratory syncytial virus infection |
TW200522976A (en) * | 2003-09-19 | 2005-07-16 | Novo Nordisk As | Novel plasma protein affinity tags |
KR101241862B1 (ko) * | 2003-09-19 | 2013-03-13 | 노보 노르디스크 에이/에스 | 신규 glp-1 유도체 |
WO2006097538A1 (fr) | 2005-03-18 | 2006-09-21 | Novo Nordisk A/S | Composes glp-1 avances |
TWI372629B (en) | 2005-03-18 | 2012-09-21 | Novo Nordisk As | Acylated glp-1 compounds |
CA2733200A1 (fr) | 2008-08-06 | 2010-02-11 | Novo Nordisk Health Care Ag | Proteines conjuguees a efficacite in vivo prolongee |
CN102292349B (zh) | 2009-01-22 | 2016-04-13 | 诺沃—诺迪斯克保健股份有限公司 | 稳定的生长激素化合物 |
CN102612376A (zh) | 2009-08-06 | 2012-07-25 | 诺沃-诺迪斯克保健股份有限公司 | 具有延长的体内功效的生长激素 |
CN106139158A (zh) | 2010-01-22 | 2016-11-23 | 诺沃—诺迪斯克保健股份有限公司 | 体内功效延长的生长激素 |
EP2590675B1 (fr) | 2010-07-07 | 2018-08-29 | Artificial Cell Technologies, Inc. | Compositions antigéniques du virus respiratoire syncytial et méthodes associées |
US11045523B2 (en) | 2013-04-05 | 2021-06-29 | Novo Nordisk Healthcare Ag | Formulation of growth hormone albumin-binder conjugate |
WO2024084785A1 (fr) * | 2022-10-20 | 2024-04-25 | 一般財団法人阪大微生物病研究会 | Composition appropriée pour être utilisée en tant que vaccin contre le virus rs |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995027787A1 (fr) * | 1994-04-06 | 1995-10-19 | Pierre Fabre Medicament | Fragment peptidique de la proteine g du virus respiratoire syncytial, agent immunogene, composition pharmaceutique le contenant et procede de preparation |
WO1996014409A1 (fr) * | 1994-11-07 | 1996-05-17 | Pierre Fabre Medicament | Production de peptides recombinants, analogues de peptides naturels hydrophobes |
WO1999003987A2 (fr) * | 1997-07-17 | 1999-01-28 | Pierre Fabre Medicament | Epitopes du vrs et anticorps les comportant, utiles dans le diagnostic et la therapie |
-
2001
- 2001-01-23 FR FR0100875A patent/FR2819810B1/fr not_active Expired - Fee Related
-
2002
- 2002-01-23 WO PCT/FR2002/000270 patent/WO2002058725A2/fr not_active Application Discontinuation
- 2002-01-23 AU AU2002233457A patent/AU2002233457A1/en not_active Abandoned
- 2002-01-23 EP EP02700379A patent/EP1353690A2/fr not_active Withdrawn
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995027787A1 (fr) * | 1994-04-06 | 1995-10-19 | Pierre Fabre Medicament | Fragment peptidique de la proteine g du virus respiratoire syncytial, agent immunogene, composition pharmaceutique le contenant et procede de preparation |
WO1996014409A1 (fr) * | 1994-11-07 | 1996-05-17 | Pierre Fabre Medicament | Production de peptides recombinants, analogues de peptides naturels hydrophobes |
WO1999003987A2 (fr) * | 1997-07-17 | 1999-01-28 | Pierre Fabre Medicament | Epitopes du vrs et anticorps les comportant, utiles dans le diagnostic et la therapie |
Non-Patent Citations (4)
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9211342B2 (en) | 2010-01-22 | 2015-12-15 | Novo Nordisk Healthcare Ag | Stable growth hormone compounds resistant to proteolytic degradation |
Also Published As
Publication number | Publication date |
---|---|
FR2819810B1 (fr) | 2004-05-28 |
FR2819810A1 (fr) | 2002-07-26 |
EP1353690A2 (fr) | 2003-10-22 |
AU2002233457A1 (en) | 2002-08-06 |
WO2002058725A2 (fr) | 2002-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002096937A3 (fr) | Vaccin destine a la prevention et au traitement de la maladie d'alzheimer et d'autres maladies associees au substances amyloides | |
PT1409692E (pt) | Novos péptidos do derivados da proteína g do vírus respiratório sincicial (vrs) e sua utilização numa vacina | |
WO2003011899A3 (fr) | Polypeptides antigeniques | |
WO2001039796A3 (fr) | Vaccin destine a la prevention et au traitement de la maladie d'alzheimer et d'autres maladies associees aux substances amyloides | |
AU2002336148A1 (en) | Novel peptides of the respiratory syncytial virus (RSV) G protein and their use in a vaccine | |
WO2006034292A3 (fr) | Anticorps dirige contre le virus respiratoire syncytial et procedes de production de vaccins associes | |
WO2002058725A3 (fr) | Peptides non glycosyles derives de la proteine g du vrs et leur utilisation dans un vaccin | |
WO2006005707A3 (fr) | Methode de prevention et de traitement de la maladie d'alzheimer | |
WO2001058485A3 (fr) | Anticorps monoclonaux a vocation prophylactique et therapeutique | |
WO2004080403A3 (fr) | Vaccin contre le virus de la grippe | |
WO2004014418A3 (fr) | Composition vaccinale | |
CY1107146T1 (el) | Μεθοδοι για προληψη και θεραπεια ασθενειας alzheimer (ad) | |
HK1070078A1 (en) | Wt1 modified peptide | |
ZA200306234B (en) | Phenethanolamine derivatives for treatment of respiratory diseases. | |
WO2003028760A3 (fr) | Vaccin | |
WO2002059143A3 (fr) | Peptides therapeutiques pour troubles de la demyelinisation | |
HUP0302636A2 (hu) | Hasított burkolt víruskészítmény | |
WO2003063899A3 (fr) | Adjuvant de vaccin | |
WO2006007555A3 (fr) | Antigenes de rotavirus | |
ZA200205408B (en) | Process for the preparation of peptides. | |
WO2003049765A3 (fr) | Vaccin contre des virus enveloppes et methode de production | |
WO2006018431A3 (fr) | Peptides pour le traitement d'infections par le virus de l'herpes | |
WO2003055440A3 (fr) | Compositions et methodes de traitement de maladies d'origine immune | |
WO2004092207A3 (fr) | Peptides du virus respiratoire syncytial (rsv) | |
UA83989C2 (ru) | Выделенный пептид, который стимулирует противоопухолевый иммунный ответ, фармацевтическая композиция на его основе и ее применение |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU BR CA CN JP MX US ZA |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AU BR CA CN JP MX US ZA |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2002700379 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2002700379 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2002700379 Country of ref document: EP |